C

Celldex Therapeutics
D

CLDX

21.350
USD
-1.10
(-4.90%)
مغلق
حجم التداول
19,910
الربح لكل سهم
-3
العائد الربحي
-
P/E
-8
حجم السوق
1,416,449,439
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    AMGN
    6.73
    (2.22%)
    309.88 USD
    AZN
    AZN
    0.480
    (0.65%)
    74.700 USD
    BMY
    BMY
    2.040
    (3.65%)
    57.880 USD
    GILD
    GILD
    1.100
    (1.00%)
    111.020 USD
    MRK
    MRK
    1.780
    (1.99%)
    91.280 USD
    NVS
    NVS
    -0.180
    (-0.16%)
    109.190 USD
    PFE
    PFE
    0.360
    (1.37%)
    26.665 USD
    المزيد
الأخبار
المقالات

العنوان: Celldex Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.